DJI46,558.47-0.26%
GDAXI23,447.29-0.60%
GSPC6,632.19-0.61%
HSI25,465.60-0.98%
IXIC22,105.36-0.93%
N22553,819.61-1.16%
AAPL250.12-2.21%
AMZN207.67-0.89%
CL98.71+3.11%
EURUSD1.1423-0.82%
GBPUSD1.3223-0.93%
GC5,061.70-1.25%
GOOG301.46-0.58%
JPM283.44+0.19%
META613.71-3.83%
MSFT395.55-1.58%
NVDA180.25-1.59%
TSLA391.20-0.96%
DJI46,558.47-0.26%
GDAXI23,447.29-0.60%
GSPC6,632.19-0.61%
HSI25,465.60-0.98%
IXIC22,105.36-0.93%
N22553,819.61-1.16%
AAPL250.12-2.21%
AMZN207.67-0.89%
CL98.71+3.11%
EURUSD1.1423-0.82%
GBPUSD1.3223-0.93%
GC5,061.70-1.25%
GOOG301.46-0.58%
JPM283.44+0.19%
META613.71-3.83%
MSFT395.55-1.58%
NVDA180.25-1.59%
TSLA391.20-0.96%
DJI46,558.47-0.26%
GDAXI23,447.29-0.60%
GSPC6,632.19-0.61%
HSI25,465.60-0.98%
IXIC22,105.36-0.93%
N22553,819.61-1.16%
AAPL250.12-2.21%
AMZN207.67-0.89%
CL98.71+3.11%
EURUSD1.1423-0.82%
GBPUSD1.3223-0.93%
GC5,061.70-1.25%
GOOG301.46-0.58%
JPM283.44+0.19%
META613.71-3.83%
MSFT395.55-1.58%
NVDA180.25-1.59%
TSLA391.20-0.96%
LIVE
USA Investors Business Daily EN

Stocks Showing Improved Relative Strength: Natera

Natera shows rising price performance, earning an upgrade to its IBD Relative Strength Rating The post Stocks Showing Improved Relative Strength: Natera appeared first on Investor's Business Daily.

Mar 10, 2026 &03001010202631; 07:00 UTC www.investors.com
Read original on www.investors.com ↗
Positive for markets
Sentiment score: +65/100
Moderate impact Short-term (days)
WHAT THIS MEANS
Natera has received an upgrade to its IBD Relative Strength Rating, indicating improved price performance relative to the broader market. This technical improvement suggests strengthening momentum in the stock.
AI CONFIDENCE
70% High
SENTIMENT GAUGE
NEWS POWER SCORE
AFFECTED ASSETS
NTRA
NTRAStock
Expected to rise
IBD Relative Strength Rating upgrade indicates improving price momentum and outperformance versus market peers
S&P 500
^GSPCIndex
High volatility expected
Healthcare/biotech sector performance may influence broader market sentiment
PRICE HISTORY
Loading chart...
SUGGESTED ACTION
Consider accumulating NTRA on dips given the positive technical upgrade and improving relative strength. Monitor for breakout above recent resistance levels as confirmation of sustained momentum.
KEY SIGNALS
IBD Relative Strength Rating upgradeRising price performanceImproved technical momentumOutperformance vs. market peers
SECTORS INVOLVED
HealthcareBiotechnologyDiagnostics
Analysis generated on Mar 11, 2026 at 04:08 UTC
Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Investors Business Daily. Always conduct your own research and consult a qualified financial advisor before making investment decisions.